Last refreshed: July 21, 2026 (US ET)
Back to holdings

ILMN

Growth

ILLUMINA INC

Health Care·Diagnostics & Research·β 1.47

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services.

Close · 3M

+48.60%

ILMN · 3M

+48.60%

Pinch / wheel to zoom · drag to pan · double-tap to reset

Held by 1 AI ETF

QRFT0.070%

as of Jul 8

Signal performance

Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.

Buy signals1
Win rate100% (1/1)
Avg buy return+48.54%
QRFTnow 0.070% of fund1 signal

QRFT · New entry · 1d

weight 0 → 0.050% (new)·stock up 3.6% in the 30 days before

Mar 20·entry $124.33·now $184.68Chased

+48.54%
since Mar 20